Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: Long-term outcome analysis

Author:

Hu Hong Tao1,Yao Quan Jun1,Meng Yan Li1,Li Hai Liang1,Zhang Hao1,Luo Jun Peng1,Guo Chen Yang1,Geng Xiang1

Affiliation:

1. Department of Radiology and Research Institute of Radiology; The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital; Zhengzhou Henan China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

2. Treatment modalities for hepatocellular carcinoma;Hung;Curr. Cancer Drug Targets,2005

3. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey;Ikai;Cancer,2004

4. Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma;Yoon;Ann. Surg. Oncol.,2010

5. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells;Chen;Blood,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3